Lenvaxen 10mg Capsule (Lenvatinib)

Lenvaxen 10mg Capsule is a targeted therapy-based anticancer medicine. It is used in the treatment of various types of cancer, including differentiated thyroid cancer, liver cancer, kidney cancer, and endometrial cancer. It contains Lenvatinib as an active ingredient that belongs to the tyrosine kinase inhibitor (TKI) class of drugs. It works by blocking the action of a specific protein to stop the growth and multiplication of cancer cells and the formation of new blood vessels. Lenvatinib 10mg capsule is used in differentiated thyroid cancer that is no longer responsive to radioactive iodine therapy and advanced renal cell carcinoma in combination therapy.

The capsule must be taken orally and swallowed whole with water and should not be crushed, chewed, or opened. The prescribed dose and duration of the Lenvatinib 10mg capsule depend on the patient's condition and response to treatment. It can also be taken with or without food. Patients are advised not to change the dosage and timings prescribed by the doctors because it can cause severe side effects.

Common side effects include tiredness, decreased appetite, nausea, vomiting, diarrhea, weight loss, mouth sores, headache, high blood pressure, and changes in thyroid function. A few patients can undergo severe side effects, including severe chest pain, difficulty breathing, severe headache or confusion, significant bleeding and severe abdominal pain. Most of the Lenvatinib 10mg capsule side effects can leave when the body adapts to the medicine. However, if any side effects persist, inform your doctor immediately.

Women who can become pregnant should use effective contraception during the treatment. Patients must list all medicines, supplements, and herbal products that they are taking. The Lenvatinib 10mg capsule must be used under medical oversight or medical supervision only. Attend regular tests and follow-ups to monitor the medicine response and reduce side effects. Before making any adjustments, changing the dose, or stopping the treatment, consult with your doctor to maximize the benefit.

Differentiated thyroid cancer, liver cancer (hepatocellular carcinoma - HCC), kidney cancer (advanced renal cell carcinoma - RCC) and Endometrial Cancer

Lenvaxen 10mg Capsule is a targeted prescription therapy medicine. It is a part of Target Therapy that belongs to the multiple kinase inhibitor class. Therefore, it comes with multiple side effects, from mild to severe. These side effects should be immediately discussed with your doctor if they persist for a longer period of time.

Common Side Effects of Lenvaxen 10mg Capsule (Lenvatinib 10mg):
● Vomiting
● Nausea
● Fatigue
● Diarrhea
● Decreased Appetite
● Abdominal Pain
● Hypothyroidism
● Hypertension
● Insomnia
● Arthralgia
● Dyspnea

Serious side effects

​● Heart Failure
● Myocardial Infarction
● Gastrointestinal Perforation
● Liver Toxicity​

Lenvaxen 10mg Capsule (Lenvatinib 10mg) is an orally administered medicine. It is must be swallowed with water, as it is. Avoid breaking, biting and chewing the capsule, as it may affect the medicine's efficacy. The dosage depends on the type of cancer, its stage and patients' overall health. Consult your doctor for your exact dosage and its timing.

● Al-Salama, Z. T., Syed, Y. Y., & Scott, L. J. (2019). Lenvatinib: a review in hepatocellular carcinoma. Drugs, 79(6), 665-674.

● Hao, Z., & Wang, P. (2020). Lenvatinib in management of solid tumors. The oncologist, 25(2), e302-e310.

● Suyama, K., & Iwase, H. (2018). Lenvatinib: a promising molecular targeted agent for multiple cancers. Cancer control, 25(1), 1073274818789361.

● Tahara, M., Kiyota, N., Yamazaki, T., Chayahara, N., Nakano, K., Inagaki, L., ... & Takahashi, S. (2017). Lenvatinib for anaplastic thyroid cancer. Frontiers in oncology, 7, 25.